Company Overview and News

 
Canada Restarts Approval Process for Trans Mountain Oil Pipeline

2018-09-21 rigzone
(Bloomberg) -- Canada has restarted efforts to build the Trans Mountain oil pipeline expansion after a court quashed its permits.
KML

1
Ottawa gives National Energy Board 22 weeks to redo review of Trans Mountain expansion

2018-09-21 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
KML KMI KMR KMRFZ CVB

9
Midstreams Going C-Corp, Should SEC Disallow The Measure Distributable Cash Flow?

2018-09-20 seekingalpha
It’s important to differentiate the concept of enterprise free cash flow valuation and the idea of capital-market dependence.
FB APLP APA SNSR AND LIT XOM BFIT GXG SIL KRMA GXF ENB CHII SEP ACTX CHIE GOEX KMI FINX CHIX MMP KMR CVB SRET BOTZ CATH KML GURX GURI MORN ALUM MILN CJHIQ URA ENB ETP LNGR COPX QQQC GURU KMRFZ FANG

 
Ottawa looks at having retired judge help guide renewed pipeline review process

2018-09-17 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
KML

2
UPDATE 2-Kinder Morgan hires TD to sell Canadian business -sources

2018-09-14 reuters
TORONTO/NEW YORK (Reuters) - Kinder Morgan Inc (KMI.N) has hired investment bank TD Securities (TD.TO) to facilitate a potential sale of its Canadian business, which could fetch as much as C$2.4 billion ($1.8 billion), people familiar with the situation told Reuters this week.
ENBBF KML MEG ENB ENB KMI MEGEF EBBNF BIP KMR CVB KMRFZ

 
KML / Kinder Morgan Canada Ltd PRE 14A

2018-09-12 sec.gov
Use these links to rapidly review the document TABLE OF CONTENTS
KML

 
Indigenous groups still want to buy stake in Trans Mountain after court setback

2018-09-10 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
KML

 
PRESS DIGEST- Canada-Sept 7

2018-09-07 reuters
Sept 7 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
KML

 
1
Kinder Morgan considers selling remaining Canadian assets after Trans Mountain sale

2018-09-06 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
KML KMI KMR KMRFZ CVB

 
Trudeau: Canada Might Appeal Ruling That Quashed Pipeline Approval

2018-09-05 rigzone
OTTAWA, Sept 5 (Reuters) - The Canadian government might appeal a court ruling that overturned federal approval of the Trans Mountain oil pipeline expansion, Prime Minister Justin Trudeau said on Wednesday.
KML

1
Kinder investors to reap profit from Canada’s pipeline bailout

2018-09-05 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
KML KMI KMR KMRFZ CVB

9
10 Oil Stocks That Are Worth a Second Look

2018-09-05 investorplace - 1
The last few weeks have been tricky ones for energy investors. Some oil stocks have struggled, while others have managed to rally. The market has taken each of these names on a case-by-case basis.
APC AMID KML XOM SRCI CTLR MDR EPD EQT KMI EGN CLR KMR CVB KMRFZ AEUA MCDFF FANG

1
Kinder Morgan (KMI) Completes Sale of Trans Mountain Project

2018-09-04 zacks
Kinder Morgan Canada Limited, a subsidiary of Kinder Morgan, Inc (KMI - Free Report) , announced that the Trans Mountain Pipeline system and the Trans Mountain Expansion Project have been indirectly purchased by the Government of Canada. The transaction was completed through Trans Mountain Corporation, a subsidiary of the Canada Development Investment Corporation. The total purchase consideration was $4.
HLX TSNU TCP KML KMI KMR KMRFZ TSN CVB

 
KML / Kinder Morgan Canada Ltd null

2018-09-02 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"CDT(# @;V)J#3P\+TQI;F5A%LY-" S M,ETO26YF;R Y,R P(%(O3&5N9W1H(#@[email protected],[email protected]+U)O;[email protected]@ M,"!2+U-I>[email protected],3(V+U1Y<&4O6%)E9B][email protected],R Q73X^
KML

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...